Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Multi-Drug Therapies Vastly Reduce China Leprosy, But Thousands Remain

This article was originally published in PharmAsia News

Executive Summary

Leprosy has yet to be eradicated in China, particularly in 10 percent of the country, despite long-term efforts by the country and multi-drug therapies introduced in the 1980s. The secretary-general of the China Leprosy Association said about 1,600 new cases are reported every year, two percent of them children. The disease is no longer considered a public health threat, but the Ministry of Health estimates there are still 6,300 leprosy patients in the country. China counted 500,000 cases in 1949. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel